We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| NewLink Genetics Corporation | NASDAQ:NLNK | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.89 | 0.85 | 0.915 | 0 | 01:00:00 |
From May 2019 to May 2024
A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.” An archived edition of the presentation will be available on the Company’s website later that day.
About NewLink Genetics Corporation
NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' leading drug candidate, indoximod, is an investigational, orally available small molecule designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.
Investor Contact:
Lisa MillerDirector of Investor RelationsNewLink Genetics515-598-2555lmiller@linkp.com
Media Contact:
Sharon CorreiaVP, Integrated CommunicationsLaVoieHealthScience617-374-8800, ext. 105scorreia@lavoiehealthscience.com
1 Year NewLink Genetics Chart |
1 Month NewLink Genetics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
